Developments of Combretastatin A-4 Derivatives as Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|4|523-538

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.4, 2011-02, pp. : 523-538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combretastatin A-4 Analogs as Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-12 ,pp. : 1186-1205

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Pyrazole amides fused Combretastatin Derivatives as Anticancer Agents

By  

Current Bioactive Compounds, Vol. 14, Iss. 4, 2018-12 ,pp. : 357-363

Bentham Science Publishers

Access to resources Recommend Favorite

Combretastatin A-4 Analogues as Antimitotic Antitumor Agents

By  

Current Medicinal Chemistry, Vol. 10, Iss. 17, 2003-09 ,pp. : 1697-1722

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Potential and Structure-Activity Relationships of Most Recently Developed Vascular Disrupting Agents: An Overview of New Derivatives of Natural Combretastatin A-4

By  

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 3035-3081

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation Of 5-hydroxy-2,3-diaryl (substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anti angiogenic and anticancer agents

By Sanna Vinod   Jaggi Manu   Kumar Vadlapudi   Burman Anand  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 363-380

Springer Publishing Company

Access to resources Recommend Favorite